The landscape of managing diabetes is advancing with the arrival of skin-applied GLP-1 therapy. These convenient delivery systems offer a potentially less invasive alternative to shots for individuals managing diabetes 2. These patches deliver a GLP-1 agonist directly through the epidermis, avoid